Literature DB >> 9639923

Lipopolysaccharide expression within the genus Bordetella: influence of temperature and phase variation.

W M van den Akker1.   

Abstract

LPSs play an important role in bacterial pathogenesis. In this study, the LPS expression of the seven known Bordetella species and its dependency on growth temperature was analysed by oxidative silver staining of proteinase-K-treated whole bacteria separated by Tricine-SDS-PAGE. The bordetellae were found to have extensively variable LPS in a species-specific way. In addition, the human and ovine Bordetella parapertussis strains exhibited host-specific LPS expression. LPSs from human B. parapertussis strains grown at 37 and 25 degrees C were distinct. Growth temperature also affected LPS production by several Bordetella bronchiseptica strains. In some of these cases, BvgAS, the global regulator of virulence factors, was involved in this regulation of LPS biosynthesis. In contrast, no evidence was found for the involvement of the Bordetella pertussis BvgAS system in regulation of LPS synthesis. The obligate human pathogens B. pertussis and Bordetella holmesii are closely related but were shown to produce immunologically distinct LPSs. These species are isolated from the upper respiratory tract and blood, respectively. This raises several interesting questions concerning the potential role of LPS as a virulence factor in the infection processes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639923     DOI: 10.1099/00221287-144-6-1527

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  21 in total

1.  Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence.

Authors:  N P West; H Jungnitz; J T Fitter; J D McArthur; C A Guzmán; M J Walker
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

2.  Interaction of Bartonella henselae with endothelial cells promotes monocyte/macrophage chemoattractant protein 1 gene expression and protein production and triggers monocyte migration.

Authors:  Amy M McCord; Andrew W O Burgess; Melissa J Whaley; Burt E Anderson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Constraint-based network model of pathogen-immune system interactions.

Authors:  Juilee Thakar; Assieh Saadatpour-Moghaddam; Eric T Harvill; Réka Albert
Journal:  J R Soc Interface       Date:  2008-10-24       Impact factor: 4.118

4.  Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection.

Authors:  E T Harvill; P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 5.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

6.  O antigen protects Bordetella parapertussis from complement.

Authors:  Elizabeth M Goebel; Daniel N Wolfe; Kelly Elder; Scott Stibitz; Eric T Harvill
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

7.  Bordetella species are distinguished by patterns of substantial gene loss and host adaptation.

Authors:  C A Cummings; M M Brinig; P W Lepp; S van de Pas; D A Relman
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

8.  O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.

Authors:  Xuqing Zhang; Maria Eugenia Rodríguez; Eric T Harvill
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

9.  Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS.

Authors:  C A Cummings; H J Bootsma; D A Relman; J F Miller
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

10.  Role of Bordetella O antigen in respiratory tract infection.

Authors:  Valorie C Burns; Elizabeth J Pishko; Andrew Preston; Duncan J Maskell; Eric T Harvill
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.